Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -196.66%-114.85K | 272.60%866.8K | 1,126.13%2.71M | -86.16%221.02K | -999.34%-2.35M | 218.43%2.95M | -55.03%118.82K | -449.15%-502.21K | 34.73%1.6M | 6,089.36%261.14K |
| Net income from continuing operations | 321.32%3.48M | 151.07%615.01K | -408.88%-2.67M | 120.93%865K | 86.58%-620.7K | 71.83%4.26M | -102.67%-1.57M | 0.43%-1.2M | -103.77%-4.13M | -10.49%-4.63M |
| Operating gains losses | ---15.27K | ---265.75K | --704.45K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -2.25%143.68K | 8.03%94.45K | -28.32%321.06K | 3.71%447.92K | -1.25%89.83K | -4.19%123.66K | 122.58%146.99K | -40.04%87.43K | 31.26%431.89K | 128.50%90.97K |
| Asset impairment expenditure | ---- | ---- | --3.17M | --0 | ---- | ---- | ---- | ---- | 5.97%2.62M | ---- |
| Remuneration paid in stock | --86.69K | --0 | 1,708.27%74.99K | -94.71%4.15K | --0 | --0 | --0 | -81.07%4.15K | -79.46%78.37K | -82.25%19.15K |
| Other non cashItems | -337.69%-3.75M | 14.72%1.05M | 239.47%1.49M | -180.13%-1.07M | 249.66%3.2M | -279.91%-6.76M | 7.61%1.58M | 25.69%915.48K | 335.72%1.33M | 47.21%913.81K |
| Change In working capital | -49.71%-53.27K | -105.02%-627.16K | -1,167.46%-375.89K | -102.82%-29.66K | -309.35%-2.16M | 2,702.86%2.47M | 93.18%-35.58K | -166.91%-305.9K | 18.13%1.05M | 73.23%1.03M |
| -Change in receivables | 356.35%744.33K | 84.31%-9.91K | -153.04%-152.48K | 377.98%287.51K | -16.23%454.03K | -107.11%-266.44K | 115.72%163.11K | -109.24%-63.18K | 107.21%60.15K | 397.84%542.01K |
| -Change in inventory | 21.08%-155.99K | -200.78%-858.29K | 129.61%161.55K | -270.72%-545.48K | -1,023.82%-3.84M | 421.78%2.64M | -244.47%-197.66K | 300.97%851.62K | -74.69%319.52K | -154.72%-341.81K |
| -Change in prepaid assets | -46.88%34K | -114.68%-50.51K | -103.86%-10.52K | 159.45%272.52K | 81.44%-76.21K | -83.67%-59.37K | 144.90%64.01K | 925.45%344.09K | -485.66%-458.44K | -3,182.09%-410.57K |
| -Change in payables and accrued expense | -938.78%-675.61K | 120.27%291.55K | 36.11%-374.43K | -151.77%-586.04K | -38.32%765.12K | 159.20%152.3K | -111.90%-65.04K | -261.76%-1.44M | 228.61%1.13M | 794.26%1.24M |
| -Change in other working capital | ---- | ---- | ---- | --541.83K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -195.96%-114.85K | 272.30%866.8K | 1,126.13%2.71M | -84.00%221.02K | 999.42%507.82K | -89.59%96.58K | -54.67%119.69K | -449.75%-503.07K | 16.59%1.38M | 1,159.40%46.19K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -42.24%-757.56K | 85.04%-509.31K | 83.34%-745.37K | -682.88%-4.47M | -1,769.04%-324.17K | 33.52%-210.76K | -7,203.84%-532.6K | -1,382.58%-3.41M | 27.71%-571.37K | -112.06%-17.34K |
| Net PPE purchase and sale | -42.24%-757.56K | 85.04%-509.31K | 84.04%-694.48K | -625.26%-4.35M | -341.39%-203.45K | 33.52%-210.76K | -7,203.84%-532.6K | -1,382.58%-3.41M | 24.08%-600.12K | -132.04%-46.09K |
| Net investment purchase and sale | ---- | ---- | 57.85%-50.88K | -519.87%-120.71K | ---- | ---- | ---- | ---- | --28.75K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -42.24%-757.56K | 85.04%-509.31K | 83.34%-745.37K | -682.88%-4.47M | -1,769.04%-324.17K | 33.52%-210.76K | -7,203.84%-532.6K | -1,382.58%-3.41M | 27.71%-571.37K | -112.06%-17.34K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -59.61%-211.59K | -117.60%-776.75K | -92.83%328.89K | 498.07%4.59M | 373.34%790.64K | -16.71%-482.55K | 41.19%-132.57K | 2,064.01%4.41M | -412.27%-1.15M | -158.74%-289.25K |
| Net issuance payments of debt | -59.61%-211.59K | -117.60%-776.75K | -135.07%-953.61K | 335.86%2.72M | -273.12%-1.08M | -16.71%-482.55K | 41.19%-132.57K | 2,064.01%4.41M | -588.73%-1.15M | -167.78%-289.25K |
| Net common stock issuance | ---- | ---- | -31.41%1.28M | --1.87M | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -59.61%-211.59K | -117.60%-776.75K | -92.83%328.89K | 498.07%4.59M | 373.34%790.64K | -16.71%-482.55K | 41.19%-132.57K | 2,064.01%4.41M | -412.27%-1.15M | -158.74%-289.25K |
| Net cash flow | ||||||||||
| Beginning cash position | 69.43%3.34M | 156.23%3.76M | 0.00%1.47M | -18.92%1.47M | -51.94%830.63K | -6.79%1.43M | 31.51%1.97M | -18.92%1.47M | 72.95%1.81M | 43.15%1.73M |
| Current changes in cash | -98.80%-1.08M | -183.08%-419.26K | 580.77%2.29M | 198.33%336.9K | 474.15%974.3K | -402.83%-596.73K | -1,840.51%-545.28K | 262.47%504.62K | -144.86%-342.61K | -141.21%-260.4K |
| End cash Position | 58.21%2.26M | 69.43%3.34M | 108.40%3.76M | 22.95%1.8M | 22.95%1.8M | -51.94%830.63K | -6.79%1.43M | 31.51%1.97M | -18.92%1.47M | -18.92%1.47M |
| Free cash from | -125.75%-932.13K | 108.94%349.49K | 148.18%1.99M | -628.68%-4.13M | 316,953.13%304.37K | -118.70%-114.18K | -260.83%-412.91K | -4,451.74%-3.91M | 98.06%781.46K | -99.93%96 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.